{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:21:06Z","timestamp":1789730466768,"version":"4.0.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00277-017-2993-y","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T22:26:24Z","timestamp":1494541584000},"page":"1241-1251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review"],"prefix":"10.1007","volume":"96","author":[{"given":"Molly","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Giustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Trinkaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Pudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Mattman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke Y.C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"2993_CR1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00043426-199302000-00012","volume":"15","author":"F Fujiwara","year":"1993","unstructured":"Fujiwara F, Hibi S, Imashuku S (1993) Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 15:92\u201398","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"2993_CR2","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","volume":"118","author":"MB Jordan","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL (2011) How I treat hemophagocytic lymphohistiocytosis. Blood 118:4041\u20134052","journal-title":"Blood"},{"key":"2993_CR3","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","volume":"78","author":"JI Henter","year":"1991","unstructured":"Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U (1991) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78:2918\u20132922","journal-title":"Blood"},{"key":"2993_CR4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)61951-7","volume":"234","author":"SR Bodley","year":"1939","unstructured":"Bodley SR, Robb-Smith A (1939) Histiocytic medullary reticulocytosis. Lancet 234:194\u2013198","journal-title":"Lancet"},{"key":"2993_CR5","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S et al (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127:2672\u20132681","journal-title":"Blood"},{"key":"2993_CR6","first-page":"997","volume":"100","author":"K Lehmberg","year":"2015","unstructured":"Lehmberg K, Nichols KE, Henter JI et al (2015) Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica 100:997\u20131004","journal-title":"Haematologica"},{"key":"2993_CR7","doi-asserted-by":"crossref","unstructured":"Ravelli A, Minoia F, Davi S et al (2016) Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol (68):566\u2013576","DOI":"10.1002\/art.39332"},{"key":"2993_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","volume":"30","author":"A Hayden","year":"2016","unstructured":"Hayden A, Park S, Giustini D, Lee AY, Chen LY (2016) Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev 30:411\u2013420","journal-title":"Blood Rev"},{"key":"2993_CR9","unstructured":"Kleynberg RL, Schiller GJ (2012) Secondary hemophagocytic lymphohistiocytosis in adults: an update on diagnosis and therapy. Clin Adv Hematol Oncol 10:726\u2013732"},{"key":"2993_CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","volume":"63","author":"GE Janka","year":"2012","unstructured":"Janka GE (2012) Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 63:233\u2013246","journal-title":"Annu Rev Med"},{"key":"2993_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PCC.0b013e3181a1ae08","volume":"10","author":"L Castillo","year":"2009","unstructured":"Castillo L, Carcillo J (2009) Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 10:387\u2013392","journal-title":"Pediatr Crit Care Med"},{"key":"2993_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","volume":"12","author":"AA Grom","year":"2016","unstructured":"Grom AA, Horne A, De Benedetti F (2016) Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol 12:259\u2013268","journal-title":"Nat Rev Rheumatol"},{"key":"2993_CR13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M et al (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131","journal-title":"Pediatr Blood Cancer"},{"key":"2993_CR14","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O et al (2014) Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66:2613\u20132620","journal-title":"Arthritis Rheumatol"},{"key":"2993_CR15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","volume":"146","author":"A Ravelli","year":"2005","unstructured":"Ravelli A, Magni-Manzoni S, Pistorio A et al (2005) Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 146:598\u2013604","journal-title":"J Pediatr"},{"key":"2993_CR16","doi-asserted-by":"crossref","first-page":"e94024","DOI":"10.1371\/journal.pone.0094024","volume":"9","author":"G Hejblum","year":"2014","unstructured":"Hejblum G, Lambotte O, Galicier L et al (2014) A web-based Delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients. PLoS One 9:e94024","journal-title":"PLoS One"},{"key":"2993_CR17","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/cncr.30084","volume":"122","author":"GN Tamamyan","year":"2016","unstructured":"Tamamyan GN, Kantarjian HM, Ning J et al (2016) Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes. Cancer 122:2857\u20132866","journal-title":"Cancer"},{"key":"2993_CR18","first-page":"29","volume":"18","author":"JI Henter","year":"1991","unstructured":"Henter JI, Elinder G, Ost A (1991) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18:29\u201333","journal-title":"Semin Oncol"},{"key":"2993_CR19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0925-5710(96)00560-9","volume":"65","author":"H Tsuda","year":"1997","unstructured":"Tsuda H (1997) Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol 65:215\u2013226","journal-title":"Int J Hematol"},{"key":"2993_CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0925-5710(97)00584-7","volume":"66","author":"S Imashuku","year":"1997","unstructured":"Imashuku S (1997) Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 66:135\u2013151","journal-title":"Int J Hematol"},{"key":"2993_CR21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2141.2009.07863.x","volume":"147","author":"S Takagi","year":"2009","unstructured":"Takagi S, Masuoka K, Uchida N et al (2009) High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. Br J Haematol 147:543\u2013553","journal-title":"Br J Haematol"},{"key":"2993_CR22","first-page":"RA179","volume":"14","author":"K Olejniczak","year":"2008","unstructured":"Olejniczak K, Kasprzak A (2008) Biological properties of interleukin 2 and its role in pathogenesis of selected diseases\u2014a review. Med Sci Monit 14:RA179\u2013RA189","journal-title":"Med Sci Monit"},{"key":"2993_CR23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1126\/science.3131876","volume":"240","author":"KA Smith","year":"1988","unstructured":"Smith KA (1988) Interleukin-2: inception, impact, and implications. Science 240:1169\u20131176","journal-title":"Science"},{"key":"2993_CR24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2009.02.005","volume":"132","author":"A Coca","year":"2009","unstructured":"Coca A, Bundy KW, Marston B, Huggins J, Looney RJ (2009) Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin. Clin Immunol 132:10\u201318","journal-title":"Clin Immunol"},{"key":"2993_CR25","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","volume":"135","author":"LA Rubin","year":"1985","unstructured":"Rubin LA, Kurman CC, Fritz ME et al (1985) Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3172\u20133177","journal-title":"J Immunol"},{"key":"2993_CR26","first-page":"597","volume":"17","author":"LA Rubin","year":"1990","unstructured":"Rubin LA, Snow KM, Kurman CC, Nelson DL, Keystone EC (1990) Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity. J Rheumatol 17:597\u2013602","journal-title":"J Rheumatol"},{"key":"2993_CR27","doi-asserted-by":"crossref","unstructured":"Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 113, 619\u2013627.","DOI":"10.7326\/0003-4819-113-8-619"},{"key":"2993_CR28","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.4049\/jimmunol.139.11.3802","volume":"139","author":"BE Tomkinson","year":"1987","unstructured":"Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL (1987) Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol 139:3802\u20133807","journal-title":"J Immunol"},{"key":"2993_CR29","first-page":"1372","volume":"9","author":"CF Monsalve-De","year":"2002","unstructured":"Monsalve-De CF, Romero TA, Estevez J et al (2002) Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases. Clin Diagn Lab Immunol 9:1372\u20131375","journal-title":"Clin Diagn Lab Immunol"},{"key":"2993_CR30","doi-asserted-by":"crossref","first-page":"e1440","DOI":"10.1542\/peds.2012-2748","volume":"132","author":"SA Rudman","year":"2013","unstructured":"Rudman SA, Walkovich K, Price S et al (2013) Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis. Pediatrics 132:e1440\u2013e1444","journal-title":"Pediatrics"},{"key":"2993_CR31","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood.V73.8.2128.2128","volume":"73","author":"DM Komp","year":"1989","unstructured":"Komp DM, McNamara J, Buckley P (1989) Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 73:2128\u20132132","journal-title":"Blood"},{"key":"2993_CR32","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","volume":"383","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta M, Bosch X (2014) Adult haemophagocytic syndrome. Lancet 383:1503\u20131516","journal-title":"Lancet"},{"key":"2993_CR33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2141.1994.tb04905.x","volume":"87","author":"K Akashi","year":"1994","unstructured":"Akashi K, Hayashi S, Gondo H et al (1994) Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol 87:243\u2013250","journal-title":"Br J Haematol"},{"key":"2993_CR34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/pbc.23384","volume":"59","author":"T Asano","year":"2012","unstructured":"Asano T, Kogawa K, Morimoto A et al (2012) Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan. Pediatr Blood Cancer 59:110\u2013114","journal-title":"Pediatr Blood Cancer"},{"key":"2993_CR35","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/cc10073","volume":"15","author":"G Beutel","year":"2011","unstructured":"Beutel G, Wiesner O, Eder M et al (2011) Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care 15:R80\u2013R87","journal-title":"Crit Care"},{"key":"2993_CR36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","volume":"56","author":"J Bleesing","year":"2007","unstructured":"Bleesing J, Prada A, Siegel DM et al (2007) The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 56:965\u2013971","journal-title":"Arthritis Rheum"},{"key":"2993_CR37","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3324\/haematol.2014.121608","volume":"100","author":"SFN Bode","year":"2015","unstructured":"Bode SFN, Ammann S, Al-Herz W et al (2015) The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica 100:978\u2013988","journal-title":"Haematologica"},{"key":"2993_CR38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13052-016-0262-7","volume":"42","author":"Y Chen","year":"2016","unstructured":"Chen Y, Wang Z, Luo Z, Zhao N, Yang S, Tang Y (2016) Comparison of Th1\/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis. Ital J Pediatr 42:50","journal-title":"Ital J Pediatr"},{"key":"2993_CR39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-3476(99)70423-3","volume":"134","author":"M Duval","year":"1999","unstructured":"Duval M, Fenneteau O, Doireau V et al (1999) Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr 134:236\u2013239","journal-title":"J Pediatr"},{"key":"2993_CR40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00043426-199302000-00012","volume":"15","author":"F Fujiwara","year":"1993","unstructured":"Fujiwara F, Hibi S, Imashuku S (1993) Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol\/Oncol 15:92\u201398","journal-title":"Am J Pediatr Hematol\/Oncol"},{"key":"2993_CR41","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.4238\/2015.May.18.21","volume":"14","author":"ZY Gao","year":"2015","unstructured":"Gao ZY, Li XY, Bhandari V, Li LD, Lan D (2015) Pre-B-cell colony-enhancing factor is markedly elevated in childhood hemophagocytic lymphohistiocytosis. Genet Mol Res 14:5287\u20135295","journal-title":"Genet Mol Res"},{"key":"2993_CR42","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3899\/jrheum.121131","volume":"40","author":"M Gorelik","year":"2013","unstructured":"Gorelik M, Fall N, Altaye M et al (2013) Follistatin-like protein 1 and the ferritin\/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 40:1191\u20131199","journal-title":"J Rheumatol"},{"key":"2993_CR43","first-page":"55","volume":"72","author":"K Honda","year":"2000","unstructured":"Honda K, Ohga S, Takada H et al (2000) Neuron-specific enolase in hemophagocytic lymphohistiocytosis: a potential indicator for macrophage activation? Int J Hematol 72:55\u201360","journal-title":"Int J Hematol"},{"key":"2993_CR44","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2298::AID-CNCR32>3.0.CO;2-#","volume":"85","author":"S Imashuku","year":"1999","unstructured":"Imashuku S, Hibi S, Tabata Y, Todo S, Ohno T (1999) Hemophagocytic syndrome in five patients with Epstein-Barr virus negative B-cell lymphoma. Cancer 85:2298\u20132299","journal-title":"Cancer"},{"key":"2993_CR45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-911X(199809)31:3<131::AID-MPO1>3.0.CO;2-C","volume":"31","author":"S Imashuku","year":"1998","unstructured":"Imashuku S, Hibi S, Tabata Y et al (1998) Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 31:131\u2013137","journal-title":"Med Pediatr Oncol"},{"key":"2993_CR46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00043426-199805000-00005","volume":"20","author":"S Imashuku","year":"1998","unstructured":"Imashuku S, Hibi S, Sako M et al (1998) Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: comparative study of 9 familial and 14 familial inheritance-unproved cases. J Pediatr Hematol Oncol 20:207\u2013214","journal-title":"J Pediatr Hematol Oncol"},{"key":"2993_CR47","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-2141.1996.d01-1727.x","volume":"93","author":"S Imashuku","year":"1996","unstructured":"Imashuku S, Hibi S, Fujiwara F, Todo S (1996) Hyper-interleukin (IL)-6-naemia in haemophagocytic lymphohistiocytosis. Br J Haematol 93:803\u2013807","journal-title":"Br J Haematol"},{"key":"2993_CR48","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1182\/blood.V86.12.4706.bloodjournal86124706","volume":"86","author":"S Imashuku","year":"1995","unstructured":"Imashuku S, Hibi S, Sako M et al (1995) Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 86:4706\u20134707","journal-title":"Blood"},{"key":"2993_CR49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10428199109107916","volume":"3","author":"S Imashuku","year":"1991","unstructured":"Imashuku S, Ikushima S, Esumi N, Todo S, Saito M (1991) Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes. Leuk Lymphoma 3:287\u2013292","journal-title":"Leuk Lymphoma"},{"key":"2993_CR50","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10067-012-1952-1","volume":"31","author":"T Kasama","year":"2012","unstructured":"Kasama T, Furuya H, Yanai R et al (2012) Correlation of serum CX3CL1 level with disease activity in adult-onset Still\u2019s disease and significant involvement in hemophagocytic syndrome. Clin Rheumatol 31:853\u2013860","journal-title":"Clin Rheumatol"},{"key":"2993_CR51","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000083450","volume":"113","author":"S Kounami","year":"2005","unstructured":"Kounami S, Yoshiyama M, Nakayama K et al (2005) Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis. Acta Haematol 113:124\u2013129","journal-title":"Acta Haematol"},{"key":"2993_CR52","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jpeds.2012.11.081","volume":"162","author":"K Lehmberg","year":"2013","unstructured":"Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G (2013) Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis. J Pediatr 162:1245\u20131251","journal-title":"J Pediatr"},{"key":"2993_CR53","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.semarthrit.2015.11.002","volume":"45","author":"A Lenert","year":"2016","unstructured":"Lenert A, Yao Q (2016) Macrophage activation syndrome complicating adult onset Still\u2019s disease: a single center case series and comparison with literature. Semin Arthritis Rheum 45:711\u2013716","journal-title":"Semin Arthritis Rheum"},{"key":"2993_CR54","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2001-12-0260","volume":"100","author":"EM Schneider","year":"2002","unstructured":"Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE (2002) Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 100:2891\u20132898","journal-title":"Blood"},{"key":"2993_CR55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pbc.24188","volume":"60","author":"RA Marsh","year":"2013","unstructured":"Marsh RA, Allen CE, McClain KL et al (2013) Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer 60:101\u2013109","journal-title":"Pediatr Blood Cancer"},{"key":"2993_CR56","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","volume":"106","author":"K Mazodier","year":"2005","unstructured":"Mazodier K, Marin V, Novick D et al (2005) Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 106:3483\u20133489","journal-title":"Blood"},{"key":"2993_CR57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fimmu.2013.00072","volume":"4","author":"S Mellor-Heineke","year":"2013","unstructured":"Mellor-Heineke S, Villanueva J, Jordan MB et al (2013) Elevated granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis. Front Immunol 4:72\u201379","journal-title":"Front Immunol"},{"key":"2993_CR58","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s002770000155","volume":"79","author":"M Miyahara","year":"2000","unstructured":"Miyahara M, Sano M, Shibata K et al (2000) B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics. Ann Hematol 79:378\u2013388","journal-title":"Ann Hematol"},{"key":"2993_CR59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12185-010-0495-y","volume":"91","author":"T Miyazaki","year":"2010","unstructured":"Miyazaki T, Kirino Y, Takeno M et al (2010) Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions. Int J Hematol 91:229\u2013237","journal-title":"Int J Hematol"},{"key":"2993_CR60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1532\/LH96.05035","volume":"12","author":"I Murohashi","year":"2006","unstructured":"Murohashi I, Yoshida K, Ihara N et al (2006) Serum levels of Thl\/Th2 cytokines, angiogenic growth factors, and other prognostic factors in young adult patients with hemophagocytic syndrome. Lab Hematol 12:71\u201374","journal-title":"Lab Hematol"},{"key":"2993_CR61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02983788","volume":"77","author":"T Ohno","year":"2003","unstructured":"Ohno T, Ueda Y, Nagai K-i et al (2003) The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell\/natural killer cell lymphomas. Int J Hematol 77:286\u2013294","journal-title":"Int J Hematol"},{"key":"2993_CR62","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1963::AID-CNCR21>3.0.CO;2-Q","volume":"82","author":"T Ohno","year":"1998","unstructured":"Ohno T, Miyake N, Hada S et al (1998) Hemophagocytic syndrome in five patients with Epstein-Barr virus negative B-cell lymphoma. Cancer 82:1963\u20131972","journal-title":"Cancer"},{"key":"2993_CR63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcmd.2015.06.009","volume":"55","author":"ZK Otrock","year":"2015","unstructured":"Otrock ZK, Gonzalez MD, Eby CS (2015) Ehrlichia-induced hemophagocytic lymphohistiocytosis: a case series and review of literature. Blood Cells Mol Dis 55:191\u2013193","journal-title":"Blood Cells Mol Dis"},{"key":"2993_CR64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.23911","volume":"90","author":"ZK Otrock","year":"2015","unstructured":"Otrock ZK, Eby CS (2015) Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 90:220\u2013224","journal-title":"Am J Hematol"},{"key":"2993_CR65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/1756-185X.12196","volume":"17","author":"VV Reddy","year":"2014","unstructured":"Reddy VV, Myles A, Cheekatla SS, Singh S, Aggarwal A (2014) Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis. Int J Rheum Dis 17:261\u2013267","journal-title":"Int J Rheum Dis"},{"key":"2993_CR66","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Campigotto F, Mullally A et al (2015) Marked hyperferritinemia does not predict for HLH in the adult population. Blood 125:1548\u20131552","journal-title":"Blood"},{"key":"2993_CR67","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/pbc.24039","volume":"59","author":"A Shiraishi","year":"2012","unstructured":"Shiraishi A, Ohga S, Doi T et al (2012) Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 59:265\u2013270","journal-title":"Pediatr Blood Cancer"},{"key":"2993_CR68","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2015.06.006","volume":"137","author":"J Sumegi","year":"2016","unstructured":"Sumegi J, Nestheide S, Aronow B et al (2016) MicroRNA activation signature in patients with hemophagocytic lymphohistiocytosis and reversibility with disease-specific therapy. J Allergy Clin Immunol 137:309\u2013312","journal-title":"J Allergy Clin Immunol"},{"key":"2993_CR69","doi-asserted-by":"crossref","unstructured":"Tabata R, Tabata C (2012) Possible prediction of underlying lymphoma by high sIL-2R\/ferritin ratio in hemophagocytic syndromes. Ann Hematol 91:63\u201371","DOI":"10.1007\/s00277-011-1239-7"},{"key":"2993_CR70","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","volume":"93","author":"T Tsuji","year":"2014","unstructured":"Tsuji T, Hirano T, Yamasaki H, Tsuji M, Tsuda H (2014) A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol 93:821\u2013826","journal-title":"Ann Hematol"},{"key":"2993_CR71","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/pbc.20511","volume":"46","author":"I Ueda","year":"2006","unstructured":"Ueda I, Ishii E, Morimoto A, Ohga S, Sako M, Imashuku S (2006) Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL). Pediatr Blood Cancer 46:482\u2013488","journal-title":"Pediatr Blood Cancer"},{"key":"2993_CR72","first-page":"1","volume":"31","author":"DX Wu","year":"2012","unstructured":"Wu DX, Wang Z, Wang XL, Lin RR, Liu N, Zhang J (2012) Significance of serum CD25:serum ferritin in the diagnosis of lymphoma-associated hemophagocytic syndrome. J Leuk Lymphoma 31:1\u20137","journal-title":"J Leuk Lymphoma"},{"key":"2993_CR73","first-page":"1838","volume":"35","author":"N Yajima","year":"2008","unstructured":"Yajima N, Wakabayashi K, Odai T et al (2008) Clinical features of hemophagocytic syndrome in patients with dermatomyositis. J Rheumatol 35:1838\u20131841","journal-title":"J Rheumatol"},{"key":"2993_CR74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10428194.2015.1048442","volume":"57","author":"YQ Yang","year":"2016","unstructured":"Yang YQ, Ding CY, Xu J et al (2016) Exploring the role of bone marrow increased FDG uptake on PET\/CT in patients with lymphoma-associated hemophagocytic lymphohistiocytosis: a reflection of bone marrow involvement or cytokine storm? Leuk Lymphoma 57:291\u2013298","journal-title":"Leuk Lymphoma"},{"key":"2993_CR75","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bjh.13461","volume":"170","author":"T Yasumi","year":"2015","unstructured":"Yasumi T, Hori M, Hiejima E et al (2015) Laboratory parameters identify familial haemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosis. Br J Haematol 170:532\u2013538","journal-title":"Br J Haematol"},{"key":"2993_CR76","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3109\/10428194.2011.566394","volume":"52","author":"L Zhang","year":"2011","unstructured":"Zhang L, Zhang S, Xu J et al (2011) Significance of soluble interleukin-2 receptor in patients with hemophagocytic lymphohistiocytosis. Leukemia & Lymphoma 52:1360\u20131362","journal-title":"Leukemia & Lymphoma"},{"key":"2993_CR77","unstructured":"Buchhorn R, Muller C, Manhardt LB, Willaschek C, Schneider EM, Stuth EA (2010) Beta-blocker therapy and hemophagocytic lymphohistiocytosis: a case report. Cardiol Res Pract 912757\u2013912754"},{"key":"2993_CR78","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jpeds.2013.10.044","volume":"164","author":"F DiPaola","year":"2014","unstructured":"DiPaola F, Grimley M, Bucuvalas J (2014) Pediatric acute liver failure and immune dysregulation. J Pediatr 164:407\u2013409","journal-title":"J Pediatr"},{"key":"2993_CR79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hon.2174","volume":"34","author":"S Faguer","year":"2016","unstructured":"Faguer S, Vergez F, Peres M et al (2016) Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells\/NK cells expansion in refractory hemophagocytic lymphohistiocytosis. Hematol Oncol 34:55\u201357","journal-title":"Hematol Oncol"},{"key":"2993_CR80","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2141.1991.tb08029.x","volume":"79","author":"S Imashuku","year":"1991","unstructured":"Imashuku S, Okuda T, Yoshihara T, Ikushima S, Hibi S (1991) Cytokine levels in aggressive natural killer cell leukaemia and malignant histiocytosis. Br J Haematol 79:132\u2013133","journal-title":"Br J Haematol"},{"key":"2993_CR81","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ajh.21236","volume":"83","author":"RL Olin","year":"2008","unstructured":"Olin RL, Nichols KE, Naghashpour M et al (2008) Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol 83:747\u2013749","journal-title":"Am J Hematol"},{"key":"2993_CR82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mpo.1294","volume":"38","author":"M Tomaske","year":"2002","unstructured":"Tomaske M, Amon O, Bosk A, Handgretinger R, Schneider EM, Niethammer D (2002) Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 38:141\u2013142","journal-title":"Med Pediatr Oncol"},{"key":"2993_CR83","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1016\/S0168-8278(16)00374-3","volume":"64","author":"A Amir","year":"2016","unstructured":"Amir A, Ling S, Naqvi A et al (2016) Liver transplantation for children with acute liver failure associated with secondary haemophagocytic lymphohistiocytosis. J Hepatol 64:S295\u2013S296","journal-title":"J Hepatol"},{"key":"2993_CR84","doi-asserted-by":"crossref","unstructured":"Cai Q, Huang HQ, Bai B et al (2013) The serum spectrum of cytokines in patients with NK\/T-cell lymphoma and its clinical significance in survival. Blood 122:1759","DOI":"10.1182\/blood.V122.21.1759.1759"},{"key":"2993_CR85","first-page":"2","volume":"67","author":"B Goldberg","year":"2015","unstructured":"Goldberg B, Muscal E, De Guzman M, Allen C (2015) Development of systemic juvenile idiopathic arthritis manifestations following remission of hemophagocytic lymphohistiocytosis. Arthritis Rheumatol 67:2","journal-title":"Arthritis Rheumatol"},{"key":"2993_CR86","unstructured":"Nanno S, Koh H, Katayama T. et al. (2015) Plasma levels of presepsin (soluble CD14-subtype) as a novel prognostic marker for hemophagocytic syndrome. In 20th Congress of the European Hematology Association Vienna, Austria, Haematologica, 557."},{"key":"2993_CR87","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1040-8428(02)00117-8","volume":"44","author":"S Imashuku","year":"2002","unstructured":"Imashuku S (2002) Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44:259\u2013272","journal-title":"Crit Rev Oncol Hematol"},{"key":"2993_CR88","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2141.2003.04726.x","volume":"124","author":"GE Janka","year":"2004","unstructured":"Janka GE, Schneider EM (2004) Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 124:4\u201314","journal-title":"Br J Haematol"},{"key":"2993_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2010.11.006","volume":"364","author":"TS Johnson","year":"2011","unstructured":"Johnson TS, Villanueva J, Filipovich AH, Marsh RA, Bleesing JJ (2011) Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders. J Immunol Methods 364:1\u201313","journal-title":"J Immunol Methods"},{"key":"2993_CR90","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/asheducation-2011.1.178","volume":"2011","author":"S Weitzman","year":"2011","unstructured":"Weitzman S (2011) Approach to hemophagocytic syndromes. Hematology 2011:178\u2013183","journal-title":"Hematology"},{"key":"2993_CR91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/bjh.12138","volume":"160","author":"K Lehmberg","year":"2013","unstructured":"Lehmberg K, Ehl S (2013) Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol 160:275\u2013287","journal-title":"Br J Haematol"},{"key":"2993_CR92","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12098-016-2037-y","volume":"83","author":"M Madkaikar","year":"2016","unstructured":"Madkaikar M, Shabrish S, Desai M (2016) Current updates on classification, diagnosis and treatment of hemophagocytic lymphohistiocytosis (HLH). Indian J Pediatr 83:434\u2013443","journal-title":"Indian J Pediatr"},{"key":"2993_CR93","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood-2011-08-374199","volume":"119","author":"YT Bryceson","year":"2012","unstructured":"Bryceson YT, Pende D, Maul-Pavicic A et al (2012) A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood 119:2754\u20132763","journal-title":"Blood"},{"key":"2993_CR94","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/pbc.24373","volume":"60","author":"JR Wu","year":"2013","unstructured":"Wu JR, Yuan LX, Ma ZG, Chen XX, Gu L, Gao J (2013) GDF15-mediated upregulation of ferroportin plays a key role in the development of hyperferritinemia in children with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 60:940\u2013945","journal-title":"Pediatr Blood Cancer"},{"key":"2993_CR95","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","volume":"104","author":"MB Jordan","year":"2004","unstructured":"Jordan MB, Hildeman D, Kappler J, Marrack P (2004) An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 104:735\u2013743","journal-title":"Blood"},{"key":"2993_CR96","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","volume":"208","author":"EE Zoller","year":"2011","unstructured":"Zoller EE, Lykens JE, Terrell CE et al (2011) Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med 208:1203\u20131214","journal-title":"J Exp Med"},{"key":"2993_CR97","doi-asserted-by":"crossref","unstructured":"Bracaglia C, de Graaf K, Pires Marafon D et al (2017) Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis 76:166\u2013172","DOI":"10.1136\/annrheumdis-2015-209020"},{"key":"2993_CR98","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood-2004-05-1973","volume":"104","author":"EM Schneider","year":"2004","unstructured":"Schneider EM (2004) Bullfight without killers: interferon rules pathology in HLH. Blood 104:600\u2013601","journal-title":"Blood"},{"key":"2993_CR99","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG (2012) Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76:16\u201332","journal-title":"Microbiol Mol Biol Rev"},{"key":"2993_CR100","doi-asserted-by":"crossref","unstructured":"La Rosee P. (2016) Alleviating the storm: ruxolitinib in HLH. Blood 127:1626\u20131627","DOI":"10.1182\/blood-2016-02-697151"},{"key":"2993_CR101","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pcl.2012.03.002","volume":"59","author":"SW Canna","year":"2012","unstructured":"Canna SW, Behrens EM (2012) Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatr Clin N Am 59:329\u2013344","journal-title":"Pediatr Clin N Am"},{"key":"2993_CR102","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.39329","volume":"68","author":"SW Canna","year":"2016","unstructured":"Canna SW, Nigrovic PA (2016) Editorial: 21st century storm chasers: defining macrophage activation syndrome. Arthritis Rheumatol 68:557\u2013560","journal-title":"Arthritis Rheumatol"},{"key":"2993_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13547500701674063","volume":"13","author":"E Bien","year":"2008","unstructured":"Bien E, Balcerska A (2008) Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers 13:1\u201326","journal-title":"Biomarkers"},{"key":"2993_CR104","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1155\/MI.2005.121","volume":"2005","author":"AM Witkowska","year":"2005","unstructured":"Witkowska AM (2005) On the role of sIL-2R measurements in rheumatoid arthritis and cancers. Mediat Inflamm 2005:121\u2013130","journal-title":"Mediat Inflamm"},{"key":"2993_CR105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0090-1229(87)90095-X","volume":"45","author":"BE Kloster","year":"1987","unstructured":"Kloster BE, John PA, Miller LE et al (1987) Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS. Clin Immunol Immunopathol 45:440\u2013446","journal-title":"Clin Immunol Immunopathol"},{"key":"2993_CR106","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1182\/blood.V78.10.2626.2626","volume":"78","author":"L Prin","year":"1991","unstructured":"Prin L, Plumas J, Gruart V et al (1991) Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood 78:2626\u20132632","journal-title":"Blood"},{"key":"2993_CR107","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1080\/10428194.2016.1195498","volume":"57","author":"N Tomita","year":"2016","unstructured":"Tomita N, Suzuki T, Miyashita K et al (2016) The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma. Leuk Lymphoma 57:2763\u20132770","journal-title":"Leuk Lymphoma"},{"key":"2993_CR108","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.2016.68.1619","volume":"35","author":"M Yamaguchi","year":"2017","unstructured":"Yamaguchi M, Suzuki R, Oguchi M et al (2017) Treatments and outcomes of patients with extranodal natural killer\/T-cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan. J Clin Oncol 35:32\u201339","journal-title":"J Clin Oncol"},{"key":"2993_CR109","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s12185-009-0304-7","volume":"89","author":"Y Masaki","year":"2009","unstructured":"Masaki Y, Dong L, Nakajima A et al (2009) Intravascular large B cell lymphoma: proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition. Int J Hematol 89:600\u2013610","journal-title":"Int J Hematol"},{"key":"2993_CR110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/10428194.2016.1190975","volume":"58","author":"K Umino","year":"2017","unstructured":"Umino K, Fujiwara SI, Ito S et al (2017) Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma. Leuk Lymphoma 58:316\u2013323","journal-title":"Leuk Lymphoma"},{"key":"2993_CR111","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MPG.0b013e31827a78b2","volume":"56","author":"J Bucuvalas","year":"2013","unstructured":"Bucuvalas J, Filipovich L, Yazigi N et al (2013) Immunophenotype predicts outcome in pediatric acute liver failure. J Pediatr Gastroenterol Nutr 56:311\u2013315","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2993_CR112","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.1302282","volume":"192","author":"TS Johnson","year":"2015","unstructured":"Johnson TS, Terrell CE, Millen SH, Katz JD, Hildeman DA, Jordan MB (2015) Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol 192:84\u201391","journal-title":"J Immunol"},{"key":"2993_CR113","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty M (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21:1387\u20131394","journal-title":"Leukemia"},{"key":"2993_CR114","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2567.2009.03115.x","volume":"128","author":"Y Hu","year":"2009","unstructured":"Hu Y, Turner MJ, Shields J et al (2009) Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model. Immunology 128:260\u2013270","journal-title":"Immunology"},{"key":"2993_CR115","unstructured":"Novimmune SA (2013) Long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), [cited 2017 Feb 27]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02069899 ."},{"key":"2993_CR116","unstructured":"Children\u2019s Hospital Medical Center (2016) Hybrid immunotherapy for hemophagocytic lympho histiocytosis. In: ClinicalTrials.gov [internet]. Bethesda (MD): National Library of Medicine (US). [cited 2017 Feb 27]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01104025 . Jan 10, 2016."}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-2993-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-2993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T10:37:22Z","timestamp":1692787042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-2993-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":116,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["2993"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-2993-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]}}}